For innovative biotech companies, the path to success is paved with more than just groundbreaking treatments; it’s about the holistic patient experience. Our latest insights reveal how patient support programs (PSPs) are not just a value-add but a strategic necessity in today’s healthcare landscape, especially within the rare disease sector in Europe. However, launching a successful PSP in Europe requires a comprehensive understanding of the European landscape. Recognising the challenges and implementing effective strategies are crucial to ensuring the ongoing success of your product. Download our exclusive guide to learn how to launch a successful PSP for rare disease patients across Europe. 👉 https://lnkd.in/dBk6RAq9 #PatientSupportProgram #Biotech #RareDiseases #EuropePSP #OrphanDrugs #SciensusOfUs
Sciensus - Rare Disease Services’ Post
More Relevant Posts
-
Take Your Practice to New Heights 🚀 : Discover the Latest in #Pharmacotherapy! Delve into groundbreaking developments in drug innovation, progressive therapies, and leading-edge research that is molding the pharmacotherapy field. Acquire valuable insights into critical updates on disease states, emerging trends, and pressing issues directly influencing your practice. Seize the chance to engage in this transformative pharmacotherapy experience. Secure your spot today and become a trailblazer in the future of healthcare! https://bit.ly/48hyKTG
To view or add a comment, sign in
-
Today's STAT 2024 Breakthrough SUMMIT in East NY was a truly insightful experience. The speakers, who represented many disciplines of medicine, were 100% focused on patient care and access. It was refreshing to hear from top experts, CEOs, and patients on how to ensure that science benefits those who need it most. One of the highlights of the summit was Nora Volkow, M.D., Director of the National Institute on Drug Abuse, who addressed the ongoing #opioidcrisis and the need for better access to care and life-saving medications. Her insights were truly inspiring. As someone who works in the industry, I was impressed with the panels and discussions among attendees. It was great to see companies like Speranza Therapeutics at the forefront of addressing challenges, including increased AMA rates, limited access to medications, breaking the stigma associated with medication treatment and the disease itself, and partnering with treatment centers across the country to treat the ever-growing symptoms that accompany withdrawal. Overall, the summit was a great reminder of the importance of focusing on patients in biotech and health tech. Attending and learning from such passionate and dedicated professionals was a privilege. #patientcare #healthtech #biotech #sciencebenefits
To view or add a comment, sign in
-
175+ healthcare providers have completed DTA's CME module! After completing this activity, participants are able to: 🔹 Describe and define the International Organization for Standardization (ISO) of DTx 🔹 Identify the difference between healthcare professional and patient-facing digital health technologies 🔹List the criteria for differentiation of categories for digital health therapeutics based on 4 key areas 🔹Describe which patient populations might be impacted by the ability to access DTx. Access the CME module for free: https://lnkd.in/dEiN6d8e
To view or add a comment, sign in
-
Developing and launching orphan medications for rare diseases is a complex process. In Europe the diverse healthcare environments, regulatory frameworks, and cultural contexts add many layers of additional complexity. Within this intricate landscape Patient Support Programs can add significant value, creating a bridge between innovative, life-changing therapies and patient-centric, holistic care. 📥 Download our guide to learn how to successfully set up a PSP in Europe: https://lnkd.in/eZGMD3R9 #RareDiseases #Biotech #PatientSupportProgram #PSPs #PatientOutcomes #OrphanDrugs #LifeSciences
To view or add a comment, sign in
-
Preventive, diagnostic, reactive and in sum integrative healthcare
CEO Roche Group | Passionate about science, and committed to positively impacting people’s lives through healthcare
Keeping patients at the heart of everything we do, our ambition is clear: to prevent, stop, and cure diseases – and with that, improve outcomes and reduce costs for patients and healthcare systems worldwide. With our unique position of having Diagnostics and Pharma under one roof, we can lead the way. At Roche, we are taking bold steps to create a healthier future. I am excited to embark on this journey with the entire Roche team! Watch this video to learn more about our strategy in 180 seconds. #WeAreRoche #Healthcare #Innovation
To view or add a comment, sign in
-
The growing challenges in healthcare need more than small tweaks—they call for big, transformative changes. With both diagnostics and pharmaceuticals under one roof, we’re in a unique position to make a real difference. Our focus is simple: put patients first. We aim to prevent, stop, and even cure diseases while improving outcomes and cutting costs. By spotting high-risk patients early, diagnosing accurately, and offering targeted medicines, we can tackle major health issues like cancer, neurological conditions, and heart diseases. We’re blending innovation with technology to support patients every step of the way—from prevention to treatment and beyond. Whether it’s in hospitals or at home, we’re here to make healthcare more accessible and improve quality of life. It’s not just about science for us. We’re committed to sustainability, creating a diverse, inclusive workplace, and making a positive impact on people, communities, and the planet. Together, we’re working towards a healthier future for everyone. #WeareRoche #Healthcare #Innovation #ValueofDiagnostics
CEO Roche Group | Passionate about science, and committed to positively impacting people’s lives through healthcare
Keeping patients at the heart of everything we do, our ambition is clear: to prevent, stop, and cure diseases – and with that, improve outcomes and reduce costs for patients and healthcare systems worldwide. With our unique position of having Diagnostics and Pharma under one roof, we can lead the way. At Roche, we are taking bold steps to create a healthier future. I am excited to embark on this journey with the entire Roche team! Watch this video to learn more about our strategy in 180 seconds. #WeAreRoche #Healthcare #Innovation
To view or add a comment, sign in
-
Innovations like virtual health communities, digital therapeutics, and on-demand lab tests are transforming the healthcare landscape. Here are five trends to know: https://okt.to/wXNc1G #DKSH #DKSHInsights #digitalhealth #virtualhealth #healthcaresolutions
To view or add a comment, sign in
-
We are here to empower human centered innovations with science & smart decision making to redefine whats possible in clinical research. Follow updates to learn the Evinova journey
If you are passionate about empowering global life sciences to accelerate better health outcomes for all, follow our LinkedIn page! We will be sharing our learnings from our discussions with top 10 pharma, the latest on Global Digital Health Innovation and therapeutic area specific use cases, helping to accelerate better health outcomes across industry. If you have any questions get in touch! #Evinova #digitalsolutions #clinicaltrials #clinicaltrailresearch
To view or add a comment, sign in
-
If you are passionate about empowering global life sciences to accelerate better health outcomes for all, follow our LinkedIn page! We will be sharing our learnings from our discussions with top 10 pharma, the latest on Global Digital Health Innovation and therapeutic area specific use cases, helping to accelerate better health outcomes across industry. If you have any questions get in touch! #Evinova #digitalsolutions #clinicaltrials #clinicaltrailresearch
To view or add a comment, sign in
-
Explore the rapidly expanding field of Medtech, a thriving industry that plays a crucial role in shaping our economy, enhancing healthcare, and driving innovation. Gain valuable insights by downloading our latest report today.
Medtech is a rapidly growing industry that contributes to our economy, health, and innovation. But how much do you know about it? Download our latest report to learn more 👉 https://bit.ly/4bHHkOs The report features insights by RSM Australia's Jayesh Kapitan, Dr Rita Choueiri, Don Holley, Srdjan Dragutinovic, and Rebecca Barnes, as well as key leaders in the local and international medtech sector. Trajan Scientific and Medical Osteopore (OSX.AX) Mach7 Technologies Specialised Therapeutics #RSMAustralia #Medtech #Healthcare #Innovation
To view or add a comment, sign in
1,675 followers